Current Opinion in Neurology

Papers
(The TQCC of Current Opinion in Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Update on management of cerebral venous thrombosis78
Cortical hyperexcitability in amyotrophic lateral sclerosis: from pathogenesis to diagnosis61
Management of neuropsychiatric symptoms in dementia52
Medical technologies, telemedicine and artificial intelligence for neurotrauma and neurorehabilitation49
The recent surge of functional movement disorders: social distress or greater awareness?48
Chemotherapy and targeted therapies for meningiomas: what is the evidence?46
The role of the gut microbiome in Alzheimer's disease pathophysiology42
Editorial introductions40
Microglia in multiple sclerosis – pathogenesis and imaging39
Central nervous system adverse events of immune checkpoint inhibitors33
Primary central nervous system lymphoma: advances in its pathogenesis, molecular markers and targeted therapies33
Historical development and contemporary use of neuromodulation in human spinal cord injury29
Hereditary motor neuropathies29
Neurology education in the era of artificial intelligence29
The 2021 WHO classification of central nervous system tumors: what neurologists need to know29
Gene therapies for CMT neuropathies: from the bench to the clinic27
T cell dysfunction in glioblastoma: a barrier and an opportunity for the development of successful immunotherapies26
From basic mechanisms to therapeutic perspectives in cluster headache25
Editorial introductions24
Multiple sclerosis in China: the current state of diagnosis and management22
Updates in neuro-otology21
Editorial: Epilepsy advances in 202321
Development of neural repair therapy for chronic spinal cord trauma: soluble Nogo receptor decoy from discovery to clinical trial21
The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection21
New chronic inflammatory demyelinating polyneuropathy/Guillain–Barré syndrome guidelines – impact on clinical practise21
Update on the clinical and therapeutic aspects of myotonic dystrophy type 120
Connecting tremors – a circuits perspective20
Tuberculosis of the central nervous system: current concepts in diagnosis and treatment20
Equitable partnerships between scientists and persons living with spinal cord injury will strengthen research scope, quality, and outcomes20
Migraine in women: a review20
Burning vertex syndrome: a novel unclassified headache - its preliminary observations, and possible mechanisms20
COVID-19 related headaches: epidemiology, pathophysiology, impacts, and management19
Threat of resurgence or hope for global eradication of poliovirus?19
Thymectomy in myasthenia gravis19
Nerve ultrasound in the diagnosis of inflammatory neuropathies19
Clinical impact of molecular profiling in rare brain tumors18
Interest of rare autoantibodies in autoimmune encephalitis and paraneoplastic neurological syndromes: the utility (or futility) of rare antibody discovery18
Revascularization of arterial occlusions in posterior circulation acute ischemic stroke18
The FSHD jigsaw: are we placing the tiles in the right position?17
Acute stroke care in low and middle-income countries17
Red flags in multiple sclerosis17
Levodopa infusion therapies for Parkinson disease17
Gauging and controlling excitability in cortical disorders17
Electrical stimulation of the peripheral and central vestibular system16
MRI for the diagnosis of limb girdle muscular dystrophies16
Diet and migraine: what is proven?16
fMRI-based spatio-temporal parcellations of the human brain16
Editorial: Advances in neuro-oncology: stepping in the right direction16
Parkinson's disease – genetic cause16
Obesity-related neuropathy: the new epidemic16
Susceptibility and disease modifier genes in amyotrophic lateral sclerosis: from genetic associations to therapeutic implications15
Neurosyphilis in 202515
Recent advances in Alzheimer disease genetics15
Update on dermatomyositis15
Neuroinflammation and immunometabolism in neurodegenerative diseases15
Idiopathic intracranial hypertension: expanding our understanding15
Choroid plexuses at the interface of peripheral immunity and tissue repair in multiple sclerosis14
Dysregulation of energy homeostasis in amyotrophic lateral sclerosis14
Towards multimodal cognition-based treatment for cognitive impairment in Parkinson's disease: drugs, exercise, non-invasive brain stimulation and technologies14
Progress in spinal muscular atrophy research14
Targeting IDH1/IDH2 mutations in gliomas14
Novel approaches to treatment of leptomeningeal metastases14
Editorial: The gap between academic advances and therapy development in motor neuron disease14
Optic neuritis: current challenges in diagnosis and management14
Sex and gender differences in neurological infections13
The state of art on the use of patient reported outcomes in migraine13
Diagnosing viral encephalitis and emerging concepts13
Chronic idiopathic axonal neuropathy: antibodies, genetics, and beyond13
Monitoring multiple sclerosis: digital and fluid phase biomarkers13
Coronavirus disease 2019 infection and cerebrovascular diseases: an update on the pathophysiology and management13
Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers13
Current trend in air pollution exposure and stroke13
Visually induced dizziness13
Recent insights in striated muscle laminopathies13
New developments in diagnostics and treatment of adult-onset focal dystonia13
Current opinion: Racial and ethnic health disparities in multiple sclerosis: considering the social determinants of health12
Fluid phase biomarkers in multiple sclerosis12
Abnormal energy metabolism in ALS: a key player?12
Update on genetics of amyotrophic lateral sclerosis12
New insights in the immune treatment of Guillain–Barré syndrome12
Advanced neuroimaging techniques in epilepsy12
Recent advances in portable, low-field magnetic resonance imaging in cerebrovascular disease12
Neurocognitive and psychiatric post-coronavirus disease 2019 conditions: pathogenic insights of brain dysfunction following severe acute respiratory syndrome coronavirus 2 infection11
Update on modifiable risk factors for Alzheimer's disease and related dementias11
Imaging cortical lesions in multiple sclerosis11
Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders11
Clinical and neuroimaging features of the progressive supranuclear palsy- corticobasal degeneration continuum10
In-vivo diagnosis of cerebral amyloid angiopathy: an updated review10
Mechanisms of coronavirus infectious disease 2019-related neurologic diseases10
Pharmacotherapy of cerebellar and vestibular disorders10
Peripheral visual field loss and activities of daily living10
Current gaps in acute reperfusion therapies10
Editorial: Seizure disorders: 2023 update10
Immune checkpoint inhibitors induced side effects of the peripheral nervous system10
Editorial: Making the invisible visible: updates on vestibular neurology10
Myofibrillar myopathy: towards a mechanism-based definition as a Z-disk-opathy10
Life after autoantibody-mediated encephalitis: optimizing follow-up and management in recovering patients10
An update on psychogenic nonepileptic seizures9
Long COVID and especially headache syndromes9
Progression in multiple sclerosis – a long-term problem9
Ménière's disease: new guidelines, subtypes, imaging, and more9
Editorial: Innovation and resilience in movement disorders: abundance of creative science despite the covid-19 period9
Is calcitonin gene-related peptide a reliable biochemical marker of migraine?9
Update on novel multiple sclerosis treatments: from dismal defeat to scintillating success9
Muscle ultrasound in myopathies9
Motion sickness: current concepts and management9
Perception and control of a virtual body in immersive virtual reality for rehabilitation9
Assessing the efficacy of duration and intensity prescription for physical activity in mitigating cardiometabolic risk after spinal cord injury9
Editorial introductions9
Interrogating large multiple sclerosis registries and databases: what information can be gained?9
Multiple sclerosis: advances and challenges in diagnosis9
New and emerging pharmacologic treatments for developmental and epileptic encephalopathies9
Therapeutic thoroughfares for adults living with Pompe disease9
Progress in treatment of gliomas9
Editorial: Cerebrovascular disease9
Nonneurologic causes of binocular diplopia for the neurologist9
0.44546413421631